GLP-1 Companion Products Market Research Methodology Primary Research The latest developments within the market have been identified through inputs from different stakeholders involved in the chain, from pharma companies producing GLP-1 drugs to nutritional supplement suppliers, digital health technology companies, and wellness service contractors
Clinical trials demonstrate that semaglutide typically achieves around 15% weight loss and liraglutide 58% over 68 weeks, even with minimal physical activity
10.1194/jlr.M001958 25 ChenP.LiY.XiaoL
Read clinical review Evidence-based guide to tirzepatide (Mounjaro) dosing considerations for Hispanic and Latino patients, covering pharmacogenomics, metabolic differences, clinical trial subgroup data, and practical titration guidance
It is a long-acting analogue of amylin, a natural hormone involved in appetite and energy regulation